Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add filters








Year range
1.
Tunisie Medicale [La]. 2016; 94 (1): 6-11
in French | IMEMR | ID: emr-181771

ABSTRACT

Background: A polymorphism upstream of interleukin [IL]-28B was recently identified to be associated with a 2-fold difference in sustained virologic response [SVR] to pegylated interferon-alpha and ribavirin therapy in a large cohort of treatment-naive, adherent patients with chronic hepatitis C [CHC] virus genotype 1 [HCV-1] infection


Aim: We sought to confirm the polymorphism's clinical relevance by intention-to-treat analysis evaluating on-treatment virologic response and SVR


Methods: We perform a prospective study in gastroenterology unitof tunis'military hospital in collaboration with immunology unit, military center of blood transfusion and laboratory of biochemistry of childrens' hospital of Tunis. HCV patients were genotyped as CC, CT or TT at the polymorphic site rs12979860 and TT, TG or GG at the polymorphic site rs8099917. Viral kinetics and rates of rapid virologic response [RVR, week 4] and SVR were compared by IL-28B type in a tunisian population


Results: 154 patients including 80 healthy blood donors[sexratio: 1, mean age: 40.35 +/- 10.15 years] and 74 patients treated for CHC [39 men and 35 women; mean age = 51.7 +/- 9.4 years] were enrolled. 35.6% of patients were genotyped as CC at the polymorphic site rs12979860 and 69.1% as TT at the polymorphic site rs8099917. The CC IL-28B type at rs12979860 was associated with a greater likelihood of SVR [77% vs 31.9%; p<0.001; OR: 7.11 [2.37-21.35]] compared with CT and TT. The CC IL-28B type at rs12979860 wasn't associated with improved of rapid virologic response [RVR]. In a multivariate logistic regression model, the rs12979860 CC genotype predicted SVR [p<0.001; OR: 7.11 IC95% [2.37-21.35]]. The TT IL-28B type at rs 8099917 wasn't associated with improved RVR and SVR compared with TG and GG


Conclusion: In treatment-naive HCV patients treated with pegylated interferon and ribavirin, a polymorphism upstream CC at the site rs12979860 of IL-28B is associated with increased sustained virologic response and effectively predicts treatment outcome

3.
Tunisie Medicale [La]. 2015; 93 (7): 416-419
in French | IMEMR | ID: emr-177367

ABSTRACT

Introduction: Zenker's diverticulum is an acquired hernia from the posterior pharyngeal mucosa developed in the pharyngo-esophageal junction. The gold standard for diagnosis is pharyngo-esophageal barium swallow study. Open surgery with cricopharyngeal myotomy has long been the conventional treatment. Actually, endoscopic treatment is an efficient alternative to resolve the problem with shorter surgery duration and less complication


Aim: We report 3 cases of patients with Zenker's diverticulum treated with endoscopic approach in our department between 2013 and 2014. Case report: There were three men aged 71, 79 and 62 years admitted to our department with symptomatic Zenker's diverticulum. Predominant symptoms were dysphagia and regurgitation. Diverticulotomy with a flexible endoscope was performed for all patients, using argon plasma coagulation in the first case and a needle-knife in the two others. Hemostatic clips were placed at the end of the procedure. There was no complication in the last two cases. Perforation at the left lateral side of the cervical diverticulum was observed in the first patient solved by diet and antibiotics. We performed a pharyngo-esophageal barium swallow study before and after the intervention in all patients showing significant regression of the diverticulum and we observed a complete regression of clinical symptoms


Conclusion: Treatment with endoscopic approach using a flexible endoscope and a diverticuloscope for good exposure of the diverticulum is a safe procedure offering a rapid improvement of symptoms with a lower risk of complications and a shorter duration of hospitalization compared to surgical treatment

6.
Tunisie Medicale [La]. 2015; 93 (10): 606-611
in English | IMEMR | ID: emr-177416

ABSTRACT

Background: Gastrointestinal angiodysplasias are associated with a high bleeding risk


Aim: to evaluate the efficiency of argon plasma electrocoagulation in the treatment of gastrointestinal angiodysplasia and to identify predictive factors of success of this technique.


Methods:Retrospective study of patients with bleeding gastrointestinal angiodysplasia treated with argon plasma electrocoagulation in the digestive endoscopy unit of the military hospital in Tunis between January 2000 and December 2011


Results: 69 patients with a mean age of 68.7 years were included. The endoscopic treatment resulted in a rise in hemoglobin value from 7.3 to 9.3 g/ dl [p = 0.0001] and a decrease of transfusion requirements from 2.5 to 0.1 units of packed red cells [p <0.0001]. It allowed to avoid surgery for 93.6% of patients with complex medical history. Recurrence of bleeding was observed in 33.3% of patients after a mean time of 12.3 months. In a multivariate analysis, no factors were independently associated with the recurrence of bleeding. The overall survival without rebleeding at 1 and 2 years were 50% and 42% respectively


Conclusion: Argon plasma coagulation is an easy, effective and safe treatment of bleeding angiodysplasia. This technique is particularly interesting for patients with multiple medical problems, where surgical treatment could be burdened by significant morbidity and mortality risk

8.
Tunisie Medicale [La]. 2015; 93 (11): 668-672
in French | IMEMR | ID: emr-177433

ABSTRACT

Background: Endoscopic polypectomy is the technique of choice for resection of colorectal polyps and has a major interest in the prevention of colorectal cancer. The aim of this study was to evaluate the technique, results and tolerance of colonic polypectomy


Methods: We conducted a retrospective study including 200 consecutive patients with colorectal polyps and who underwent therapeutic endoscopic polypectomy, performed at the endoscopy unit of the Military Hospital in Tunis, between December 2008 and December 2012


Results: Hundred and forty men and 60 women were included. The average age was 58.5 +/- 14.5 years. The polyp was unique in more than half of cases. The most frequent location was the sigmoid colon [30.5%]. Approximately, [1/4] of the polyps was larger than 10 mm. According to the Paris endoscopic classification, 78% of polyps were sessile [Is]. Seventy-two percent of polyps were adenomas. Twenty five per cent of them contained a villous component, 40% were advanced adenomas and 3% malignant adenomas. Regarding polypectomy, 232 polyps [64%] were treated by the cold forceps, 68 polyps [18.5%] by the diathermic snare and 63 [17.5%] by a mucosal resection. Thirty-one percent of polypectomy were fragmented. The evaluation of the efficacy of treatment among adenomas and potentially malignant tumors, had identified 36% of treatment failure. The common independent predictive factor of fragmented resection and treatment failure were the size >/= 10 mm [p <10[-3]]. Among a total of 363 polypectomies, 23 [6.3%] were complicated, by 11 procedural bleeding, 11 micro-perforations and 1 delayed hemorrhage. The common independent predictive factor of these complications was the size >/= 10 mm [p <10[-3]]. During following, there were 12 residual polyps [6%], 36 new polyps [18%] and 6 colorectal cancers [3%]. The only independent predictive factor of an unfavorable course was the multiplicity of polyps. The colorectal polyps-free survival was 90.2% at 12 months and 88.4% at 24 months


Conclusion: The evaluation of colorectal polypectomy in our series had confirmed the effectiveness and the low morbidity of this practice. The polyp size was the only independent predictive factor of both treatment failure and complications

9.
Tunisie Medicale [La]. 2015; 93 (12): 742-745
in French | IMEMR | ID: emr-177452

ABSTRACT

Background: In front of the considerable impact of the viral hepatitis C, the prevention is more than ever a priority, based essentially on the screening


Aim: We realized an epidemiological study in a population of young recruits with the aim of considering prevalence of anti-hepatitis C Virus [anti-HCV] antibodies, describing its epidemiological evolution and establishing a cartography of the viral hepatitis C in Tunisia


Methods: Epidemiological retrospective study of prevalence was realized from the data of the screening of anti-HCV antibodies from 2003 till 2012 of all the young recruits suggested to be incorporated for the national service or suggested to be recruited as career soldier. The study was exhaustive concerning 175 322 young and healthy male adults aged between 20 and 30 years old, originating from all parts of Tunisia. The screening was realized by third and fourth generation ELISA tests then validated by Immunoblot


Results: The prevalence was 0.11% and the confirmed prevalence was 0.07%. The positive subjects were mainly between 20 and 25 years old [82.32%] and 91.05% were detected within the framework of their incorporations to the national service. The lowest prevalence was 0.07% in 2004, and the highest was 0.17% in 2011, without a significant tendency in the increase or in the decrease during the period of study [r = 0.857 ; p = 0.564]. The screening of anti-VHC antibodies had an unequal geographical distribution according to a North-South decreasing gradient. The highest proportions were registered in the North-West [23.23%] and the District of Tunis [22.73%], contrary to the South-East which was weakly affected [3.54%]. The governorates with the highest proportions were Tunis [19.19%], Bizerte [11.62%] and Jendouba [8.59%], the governorates of Monastir and Tataouine were weakly affected [0.51%]


Conclusion: Prevalence of anti-HCV antibodies in the young and male Tunisian population was weak, stable without significant tendency in the increase or in the decrease from 2003 till 2012, characterized by an unequal geographical distribution according to a North-South decreasing gradient

12.
Tunisie Medicale [La]. 2013; 91 (5): 327-331
in French | IMEMR | ID: emr-141119

ABSTRACT

The current treatment recommendation for chronic hepatitis c is the combination of peginterferon and ribavirin. To report our experience in the treatment of chronic hepatitis c and determine the predictive factors of sustained virologic response. Analysis of consecutive patients treated with peginterferon and ribavirine from 1st January 2000 and 31st December 2009. 141 patients with an average age of 50 years were included. 75% of the patients were infected by a VHc of genotype 1. 22.6% of the patients were cirrhotics. 7% of the patients [n=10] had to stop the treatment because of severe side-effects. A reduction of the dose was indicated for 16% of the patients [n=23]. Among the 117 patients with the end of treatment virologic response, 24 patients [20.5%] relapse during the 6 months after the end of therapy. The sustained virologic response in intention to treat was 66% [57.9% in case of genotype 1-4 and 91% in case of genotype 2-3]. In multivariate analysis, 4 independent factors of sustained virologic response were identified: the male gender, a viral genotype not 1, a pre-therapeutic viral load

13.
Tunisie Medicale [La]. 2013; 91 (5): 346-351
in French | IMEMR | ID: emr-141123

ABSTRACT

Gastric variceal bleeding is associated with significant morbidity and mortality. Its optimal treatment is not yet standardized and glue injection is the most often proposed treatment. The longterm results of this technique are still controversial. To assess the safety and efficacy of gastric variceal glue injection. Consecutive patients that underwent glue injection for gastric variceal bleeding in our endoscopy unit, from January 2000 to August 2011, were assessed. Sixteen patients [9 men, 7 women] underwent cyanoacrylate glue injections for gastric variceal bleeding. The median follow-up period of 13 patients was 33 months [three were lost to follow-up]. The average age was 60 years [3 - 80 years]. All patients had stigmata of recent bleeding at endoscopy. Patients underwent an average of 2 gluing sessions [1-3 sessions]. N-butyl-2-cyanoacrylate [Histoacryl [registered sign]] was the most often product used. No significant complications from cyanoacrylate injection were observed. No patient had a recurrent variceal bleeding. During the median follow-up period, two patients died. Our data suggest that cyanoacrylate injection therapy is safe and effective for the prevention of short- and long-term bleeding from gastric varices

14.
Tunisie Medicale [La]. 2008; 86 (3): 223-228
in French | IMEMR | ID: emr-134905

ABSTRACT

Malnutrition is a common problem in gastroenterology hospitalized patients. Its frequency varies considerably with the studied population and nutritional screening tools. The purpose of this study was to assess the prevalence of malnutrition in gastroenterology hospitalized patients. A prospective study was carried between January 2005 and March 2005 including 70 patients. The nutritional state of the patients was assessed according to the subjective global assessment scale [SGA]. anthropometric measurements and serum albumin level. Moderately and severely malnutrition was found for 54 patients [77 percent]. Statistical analysis found positive correlation between body mass index [BMI] and SGA C [p=0 .002] and between albumin level and SCA [p<0.005]. The median nutritional risk index [NRI] was 89.5 +/- 13 with significantly positive correlation with the other parameters [BMI, Albumin and SGA] respectively p=0.03, p=0.003 and p=0.004. Malnutrition is common in gastroenterology patients. The assessment of patient's nutritional state according to the subjective global assessment had a positive correlation with the others nutritional screening tools


Subject(s)
Humans , Male , Female , Prevalence , Prospective Studies , Hospitalization , Gastroenterology , Nutrition Assessment , Body Mass Index , Serum Albumin
SELECTION OF CITATIONS
SEARCH DETAIL